OraSure Technologies Prepare for Key Investor Conference
OraSure Technologies, Inc. (NASDAQ: OSUR) has exciting news for investors as it announces its participation in a prominent investor conference. This event is an opportunity for the company to connect with investors and stakeholders, showcasing what makes OraSure a leader in healthcare innovation.
Event Details
The Stephens Annual Investment Conference is set to take place soon, and OraSure is scheduled for a Q&A session on Wednesday, November 20, at 1 p.m. ET. This is a chance for attendees to gain insights directly from the company’s management team.
Webcast Availability
For those interested in following the event, a live webcast will be provided. After the event, a replay will be accessible on the investor relations section of OraSure's website, where it will remain available for approximately 90 days. This ensures that anyone who cannot attend live can still engage with the insights shared during the presentation.
About OraSure Technologies
Founded with a mission to transform health through actionable insight, OraSure Technologies plays a crucial role in connecting individuals to essential healthcare resources. The company specializes in creating innovative solutions that enhance access, quality, and value in healthcare through effortless testing and sample management.
Leading the Industry
OraSure Technologies has established itself as a global leader in developing and distributing rapid diagnostic tests and sample collection devices. Through its wholly-owned subsidiary, DNA Genotek Inc., they provide advanced solutions that detect critical medical conditions. Their products serve a diverse range of markets, including clinical laboratories, hospitals, and even direct consumers.
Contacting OraSure
For investors looking for more information, Jason Plagman, the VP of Investor Relations, is the contact person. He can be reached at the company’s investor email for any inquiries or further discussions regarding investment opportunities.
Media Inquiries
Amy Koch, the Director of Corporate Communications, is available for media inquiries. Her expertise ensures that all communications are handled effectively, providing clarity on the company’s strategic initiatives and innovations.
Frequently Asked Questions
What is the purpose of the Stephens Annual Investment Conference?
The conference serves as a platform for companies like OraSure Technologies to engage with investors and stakeholders, providing updates and insights into their operations and growth strategies.
When will the live webcast be available?
The live webcast of OraSure's presentation will take place on November 20, and a replay will be available on their website for 90 days after the event.
Who can I contact for investor inquiries at OraSure?
Investors can reach out to Jason Plagman, the VP of Investor Relations, for any specific queries regarding investments or corporate strategies.
What types of products does OraSure offer?
OraSure provides rapid diagnostic tests and sample collection devices aimed at improving healthcare accessibility and efficiency across various markets.
How does OraSure support public health?
By developing innovative health solutions, OraSure enhances the capabilities of healthcare practitioners and institutions globally, contributing significantly to public health initiatives.